back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-04 14:42 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-07-04 14:40 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2025-07-04 14:38 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+350,000 vol |
350,000 | |
| Filed 2025-07-04 14:36 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,700,000 vol |
5,700,000 | |
| Filed 2025-07-04 14:33 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2025-07-04 14:31 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,000,000 vol |
4,000,000 | |
| Filed 2025-07-04 14:28 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+9,200,000 vol |
9,200,000 | |
| Filed 2025-07-02 16:24 Tx date 2025-04-08 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80.00
-500 vol $0.16 each |
39,722 | |
| Filed 2025-07-02 16:23 Tx date 2025-04-08 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,800
-32,000 vol $0.15 each |
40,222 | |
| Filed 2025-03-20 18:26 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,100
+43,334 vol $0.21 each |
247,000 | |
| Filed 2025-03-20 18:25 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,334 vol |
0 | |
| Filed 2025-03-20 18:25 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,334 vol |
23,334 | |
| Filed 2025-03-20 18:23 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,100
+43,334 vol $0.21 each |
347,000 | |
| Filed 2025-03-20 18:22 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,334 vol |
0 | |
| Filed 2025-03-20 18:22 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,334 vol |
23,334 | |
| Filed 2025-03-20 18:20 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,166
+72,222 vol $0.21 each |
72,222 | |
| Filed 2025-03-20 18:19 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
0 | |
| Filed 2025-03-20 18:19 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
38,889 | |
| Filed 2025-03-20 18:17 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,999
+66,666 vol $0.21 each |
379,999 | |
| Filed 2025-03-20 18:16 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-1 vol |
0 |